BMS552 Molecular Pathology (8)
CSU Discipline Area: Biomedical Science (BIMSC)
Duration: One session
Abstract:
This subject will take a multi-disciplinary approach to the examination of the molecular basis of disease. The subject focus is on the application of molecular techniques to assist in the diagnosis of disease and how these techniques can be used to assist treatment of emerging diseases. The subject also addresses the emerging field of ''molecular medicine'' and the translational aspects of molecular pathology in areas such as pharmacogenomics and personalized medicine.
+ Subject Availability Modes and Locations
| Session 2 | |
|---|---|
| Distance | Wagga Wagga |
Continuing students should consult the SAL for current offering details: BMS552
Where differences exist between the Handbook and the SAL, the SAL should be taken as containing the correct subject offering details.
Enrolment restrictions:
Subject only available to postgraduate students
Objectives:
Upon successful completion of this subject, students should:
- Be able to describe the molecular basis of diseases
- Be able to explain how cytogenetics can be used in the diagnosis of disease
- Be able to discuss the practice of ''molecular medicine'' and the translational aspects of molecular pathology: molecular diagnostics, molecular assessment, and personalized medicine
- Be able to justify the use of a particular diagnosic technique and to assess both the benefits and limitations of the technique
- Be able critically evaluate the use of molecular techniques in the diagnosis and treatment of disease
Syllabus:
The subject will cover the following topics:
Topic 1 - Introduction to the subject (revision)
- This will contain a brief over view of classical pathology, molecular biology and genetics and integrative systems biology
Topic 2 – Molecular basis of disease
- Cardiovascular disease
- Diseases of the kidney
- Skin disease
- Diseases of the nervous system
- Pulmonary disease
Topic 3 - Diagnostic techniques
- Practice of molecular medicine
- Molecular diagnosis of human disease (including cytogenetics)
- Molecular assessment of human disease in the clinical laboratory
- Pharmacogenomics and personalized medicine in the treatment of human disease
The information contained in the 2013 CSU Handbook was accurate at the date of publication: 24 April 2013. The University reserves the right to vary the information at any time without notice.